ESG Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ESG Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.51M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $21.42M | Mar 31, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $517.5K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.55M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.75M | Apr 15, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.95M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $944.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($324.7K) | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | ($37.6K) | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | ($54.9K) | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | ($1.5K) | Nov 17, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.25M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($209.7K) | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | ($37.9K) | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | ($55.0K) | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | ($1.5K) | Nov 17, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.5K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $708.8K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $609.7K | Apr 15, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.40M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.15M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.35M | Apr 15, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.2K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.55M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $119.9K | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | ($39.7K) | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | ($40.2K) | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | ($12.4K) | Nov 17, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $178.2K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $685.1K | Mar 31, 2026 |
| FY2023 | Aug 31, 2022 | $1.3K | Oct 30, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.93M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $29.79M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $26.27M | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | $47.2K | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | $87.2K | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | $138.6K | Nov 17, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.08M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $15.98M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $13.33M | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | $1.0K | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | $3.4K | Oct 30, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.75M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $10.30M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.63M | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | $46.2K | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | $83.8K | Oct 30, 2023 |
| FY2023 | Aug 31, 2021 | $138.6K | Oct 30, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.12M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($168.6K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.11M) | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | ($93.9K) | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | ($56.4K) | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | ($1.5K) | Nov 17, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $110.3K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $342.3K | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | $6.4K | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | $86.1K | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | $127.6K | Nov 17, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14M | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $1.25M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $1.42M | Apr 15, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | 0 | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | 0 | Oct 30, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | 0 | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | 0 | Oct 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25.90M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 25.90M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 25.90M | Apr 15, 2025 |
| FY2023 | Aug 31, 2023 | 15.47M | Oct 30, 2023 |
| FY2023 | Aug 31, 2022 | 15.47M | Oct 30, 2023 |
| FY2022 | Aug 31, 2021 | 15.47M | Nov 17, 2022 |